DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994,367 | +14.0% | 4,008 | +10.3% | 0.08% | -5.0% |
| Q2 2023 | $872,494 | +28.4% | 3,635 | +34.9% | 0.08% | +86.0% |
| Q1 2023 | $679,305 | -2.9% | 2,695 | +2.2% | 0.04% | -38.6% |
| Q4 2022 | $699,662 | -61.8% | 2,636 | -57.4% | 0.07% | -1.4% |
| Q3 2022 | $1,832,000 | +198.9% | 6,195 | +156.2% | 0.07% | -16.5% |
| Q2 2022 | $613,000 | -83.2% | 2,418 | -80.6% | 0.08% | -78.3% |
| Q1 2022 | $3,651,000 | -6.4% | 12,445 | +5.0% | 0.39% | -3.0% |
| Q4 2021 | $3,900,000 | +8.5% | 11,855 | +2.8% | 0.40% | -11.4% |
| Q3 2021 | $3,594,000 | +23.5% | 11,528 | +6.3% | 0.46% | +12.0% |
| Q2 2021 | $2,911,000 | +140.6% | 10,847 | +101.6% | 0.41% | +95.7% |
| Q1 2021 | $1,210,000 | +254.8% | 5,380 | +250.0% | 0.21% | +197.1% |
| Q4 2020 | $341,000 | +19.2% | 1,537 | +15.7% | 0.07% | +2.9% |
| Q3 2020 | $286,000 | +23.3% | 1,328 | +1.2% | 0.07% | +13.3% |
| Q2 2020 | $232,000 | +7.9% | 1,312 | -19.5% | 0.06% | -14.3% |
| Q1 2019 | $215,000 | +388.6% | 1,630 | +275.6% | 0.07% | +268.4% |
| Q4 2018 | $44,000 | +29.4% | 434 | +25.8% | 0.02% | +18.8% |
| Q1 2018 | $34,000 | +6.2% | 345 | 0.0% | 0.02% | +6.7% |
| Q4 2017 | $32,000 | – | 345 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |